Sex: F
Vaccine: HPV4
Symptoms: Hyperhidrosis, Hypoaesthesia, Loss of personal independence in daily activities, Night sweats, Pelvic pain
Clinical narrative: edema; pelvis pain; abdominal cramping; excessive bleeding; leg numbness; night sweating; allergy to gluten; as well as a constellation of adverse symptoms, complications, injuries,; debilitating autoimmune, autonomic, and neurological, injuries; debilitating autoimmune, autonomic, and neurological, injuries; debilitating autoimmune, autonomic, and neurological, injuries; generalized pain; hot sweats; This initial spontaneous report was received from a lawyer and the consumer regarding a case in litigation and refers to a 22-year-old female patient. The patient's medical history, concurrent conditions and concomitant medications were not reported.   On unspecified dates, the patient received dose 1, 2 and 3 of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) administered as prophylaxis (strength, dose description, lot #, expiry date, and route of administration were not provided).  On an unknown date, Following her second quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL)  vaccine, Plaintiff experienced disabling excruciating pelvis pain, abdominal cramping, excessive bleeding, leg numbness, hot sweats, night sweating, and she developed an allergy to gluten. As a result of her post-Gardasil symptoms, Plaintiff has been unable to engage in activities that a young person her age would normally enjoy. Plaintiff enjoyed hiking and long walks. Now she finds it difficult to function in her daily life. As the months progressed, so did Plaintiff's injuries. She was seen by multiple physicians for her complaints. Based upon her chronic and severe post-Gardasil symptoms, Plaintiff continues to experience disabling excruciating pelvis pain, abdominal cramping, excessive bleeding, leg numbness, hot sweats, night sweating, and an allergy to gluten. As previously discussed, the medical literature has documented other patients who, like Plaintiff, have suffered serious autoimmune, autonomic, and neurological dysfunctions, and who experienced similar side effects as those Plaintiff has suffered, and who were diagnosed with Gardasil-induced autoimmune, autonomic, and neurological diseases. Plaintiff contends that her quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL)injection(s) caused her to develop serious and debilitating autoimmune, autonomic, and neurological, injuries, including but not limited to generalized pain, edema, excessive bleeding, hot sweats, night sweating, and an allergy to gluten as well as a constellation of adverse symptoms, complications, injuries, and other adverse events, many of which are alleged herein and all of which were caused by quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) or otherwise linked to her Gardasil-induced autoimmune disorder. As a proximate result of Merck's fraudulent, false, and misleading statements, omissions, and conduct concerning the safety and efficacy of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL), Plaintiff has suffered and continues to suffer severe and permanent physical injuries, and associated symptomology and has suffered severe and permanent emotional injuries, including pain and suffering. Plaintiff also has a substantial fear of suffering additional and ongoing harms, including but not limited to now being at an increased risk of cancer, and future symptoms and harms associated with her autoimmune disease and other injuries caused by quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL). As a direct and proximate result of her Gardasil-induced injuries, Plaintiff has suffered and continues to suffer economic losses, including considerable financial expenses for medical care and treatment, and diminished income capacity and she will continue to incur these losses and expenses in the future.  The causality between quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) and the events was reported as related. The reporter considered the events to be disabling.   The reporter considered the events of edema, pelvis pain, abdominal cramping, excessive bleeding, leg numbness, night sweating, allergy to gluten, as well as a constellation of adverse symptoms, complications, injuries,, debilitating autoimmune, autonomic, and neurological, injuries, debilitating autoimmune, autonomic, and neurological, injuries, debilitating autoimmune, autonomic, and neurological, injuries and generalized pain to be serious (medically significant).